Daewoong Pharmaceutical “Absolute misinformation in the article’Daewoong, supply of Botox to Ebolus’.. Legal response”
Daewoong Pharmaceutical’s full subsidy to US partners… Virtually part of the Botox Dispute Settlement Fund
Daewoong Pharmaceutical, joint research with AI company Oncocross to expand indications for new drugs
MEDI:GATE NEWS Daewoong Pharmaceutical’s partner, begins global phase 2 clinical trial for botulinum toxin migraine treatment